Formulation and evaluation of piroxicam transferosomal gel: An approach for penetration enhancement

Journal of Drug Delivery Science and Technology

Volumn 23, Issue 6, 2013, Pages 587-590

  Ghanbarzadeh, S ^a,b,c   Arami, S ^b,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Piroxicam; Skin permeation and deposition; Topical delivery; Transferosome

Indexed keywords

CARBOMER; LIPOSOME; PIROXICAM; POLYSORBATE 80; SORBITAN OLEATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG SAFETY; DRUG SCREENING; DRUG SOLUTION; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIGHT SCATTERING; MALE; NONHUMAN; PARTICLE SIZE; RAT; SKIN SURFACE; STEADY STATE;

EID: 84889567541     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(13)50089-X     Document Type: Article

References (41)

1. Capt A., Luzy A.P., Esdaile D., Blanck O. - Comparison of the human skin grafted onto nude mouse model with in vivo and in vitro models in the prediction of percutaneous penetration of three lipophilic pesticides. - Regul. Toxicol. Pharm., 47 (3), 274-87, 2007. (Pubitemid 46420394)
2. Gwak H.S., Chun I.K. -Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. - Int. J. Pharm., 236 (1-2), 57-64, 2002.
3. Santoyo S., Ygartua P. - Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application. - Eur. J. Pharm. Biopharm., 50 (2), 245-50, 2000.
4. Alexander A., Dwivedi S., Ajazuddin, Giri T.K., Saraf S., Saraf S., Tripathi D.K. - Approaches for breaking the barriers of drug permeation through transdermal drug delivery. - J. Control.Rel., 164(1), 26-40, 2012.
5. Barry B.W. - Novel mechanisms and devices to enable successful transdermal drug delivery. - Eur. J. Pharm. Sci., 14 (2), 101-14, 2001. (Pubitemid 32737532)
6. Cevc G. - Lipid vesicles and other colloids as drug carriers on the skin. - Adv. Drug Del. Rev., 56 (5), 675-711, 2004. (Pubitemid 38326939)
7. Cevc G., Vierl U. - Nanotechnology and the transdermal route: a state of the art review and critical appraisal. - J. Control. Rel., 141 (3), 277-99, 2010.
8. Hamidi M., Azadi A., Rafiei P. - Hydrogel nanoparticles in drug delivery. - Adv. Drug Del. Rev., 60 (15), 1638-49, 2008.
9. Karande P., Mitragotri S. - Enhancement of transdermal drug delivery via synergistic action of chemicals. - Biochim. Biophys. Acta (BBA), Biomembranes, 1788 (11), 2362-73, 2009.
10. Lassmann-Vague V., Raccah D. - Alternatives routes of insulin delivery. - Diabetes Metab., 32 (5, Part 2), 513-22, 2006.
11. Park J.W., Kirpotin D.B., Hong K., Shalaby R., Shao Y., Nielsen U.B., Marks J.D., Papahadjopoulos D., Benz C.C. - Tumor targeting using anti-her2 immunoliposomes. - J. Control. Rel., 74(1-3), 95-113, 2001. (Pubitemid 32727613)
12. Zhou W., An X., Wang J., Shen W., Chen Z., Wang X. - Characteristics, phase behavior and control release for copolymer-liposome with both pH and temperature sensitivities. - Colloids Surf. Physicochem. Eng. Aspects, 395 (0), 225-32, 2012.
13. Tardi C., Brandi M., Schubert R. - Erosion and controlled release properties of semisolid vesicular phospholipid dispersions. - J. Control. Rel., 55 (2-3), 261-70, 1998. (Pubitemid 28477617)
14. Crommelin D.J.A., Eling W.M.C., Steerenberg P.A., Nässander U.K., Storm G., De Jong W.H., Van Hoesel Q.G.C.M., Zuidema J. - Liposomes and immunoliposomes for controlled release or site specific delivery of anti-parasitic drugs and cytostatics. - J. Control. Rel., 16 (1-2), 147-54, 1991.
15. Yavlovich A., Singh A., Blumenthal R., Puri A. - A novel class of photo-triggerable liposomes containing DPPC:DC8,9PC as vehicles for delivery of doxorubcin to cells. - Biochim. Biophys. Acta (BBA), Biomembranes, 1808 (1), 117-26, 2011.
16. Caddeo C., Sales O.D., Valenti D., Saurí A.R., Fadda A.M., Manconi M. - Inhibition of skin inflammation in mice by diclofenac in vesicular carriers: liposomes, ethosomes and PEVs. - Int. J. Pharm., 443 (1-2), 128-36, 2013.
17. El Maghraby G.M.M., Williams A.C., Barry B.W. - Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. - Int. J. Pharm., 276 (1-2), 143-61, 2004. (Pubitemid 38542995)
18. Engelbrecht T.N., Schroeter A., Hauß T., Neubert R.H.H. - Lipophilic penetration enhancers and their impact to the bilayer structure of stratum corneum lipid model membranes: neutron diffraction studies based on the example oleic acid. - Biochim. Biophys. Acta (BBA), Biomembranes, 1808 (12), 2798-806, 2011.
19. Kirjavainen M., Urtti A., Valjakka-Koskela R., Kiesvaara J., Mönkkönen J. - Liposome-skin interactions and their effects on the skin permeation of drugs. - Eur. J. Pharm. Sci., 7 (4), 279-86, 1999. (Pubitemid 29080739)
20. Manconi M., Caddeo C., Sinico C., Valenti D., Mostallino M.C., Lampis S., Monduzzi M., Fadda A.M. - Penetration enhancer-containing vesicles: Composition dependence of structural features and skin penetration ability. - Eur. J. Pharm. Biopharm., 82 (2), 352-9, 2012.
21. Manconi M., Mura S., Sinico C., Fadda A.M., Vila A.O., Molina F. - Development and characterization of liposomes containing glycols as carriers for diclofenac. - Colloids Surf. Physicochem. Eng. Aspects, 342 (1-3), 53-8, 2009.
22. Malakar J., Sen S.O., Nayak A.K., Sen K.K. -Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. - Saudi Pharm. J., 20 (4), 355-63, 2012.
23. Paolino D., Cosco D., Cilurzo F., Trapasso E., Morittu V.M., Celia C., Fresta M. - Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles. - J. Control. Rel., 162 (1), 143-51, 2012.
24. Trotta M., Peira E., Carlotti M.E., Gallarate M. - Deformable liposomes for dermal administration of methotrexate. - Int. J. Pharm., 270 (1-2), 119-25, 2004. (Pubitemid 38077093)
25. Gouda A.A., Kotb El-Sayed M.I., Amin A.S., El Sheikh R. - Spectrophotometric and spectrofluorometric methods for the determination of non-steroidal anti-inflammatory drugs: a review. - Arabian J. Chemistry, 6 (2), 145-63, 2013.
26. Hadgraft J., Plessis J.d., Goosen C. - The selection of non-steroidal anti-inflammatory agents for dermal delivery. - Int. J. Pharm., 207 (1-2), 31-7, 2000.
27. McCormack K. - Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. - Pain, 59 (1), 9-43, 1994. (Pubitemid 24311167)
28. Takahashi A., Suzuki S., Kawasaki N., Kubo W., Miyazaki S., Loebenberg R., Bachynsky J., Attwood D. - Percutaneous absorption of non-steroidal anti-inflammatory drugs from in situ gelling xyloglucan formulations in rats. - Int. J. Pharm., 246 (1-2), 179-86, 2002. (Pubitemid 35247990)
29. Huang Y.-B., Wu P.-C., Ko H.-M., Tsai Y.-H. - Cardamom oil as a skin permeation enhancer for indomethacin, piroxicam and diclofenac. - Int. J. Pharm., 126 (1-2), 111-7, 1995. (Pubitemid 26018575)
30. Shin S.-C., Cho C.-W., Oh I.-J. - Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. - Int. J. Pharm., 222 (2), 199-203, 2001. (Pubitemid 32568363)
31. Santoyo S., Arellano A., Ygartua P., Martin C. - Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. - Int. J. Pharm., 117 (2), 219-24, 1995.
32. Ghanbarzadeh S., Valizadeh H., Zakeri-Milani P. - The effects of lyophilization on the physico-chemical stability of sirolimus liposomes. - Adv. Pharm. Bull., 3 (1), 25-9, 2013.
33. Ghanbarzadeh S., Valizadeh H., Zakeri-Milani P. - Application of factorial designs and response surface methodology in formulation development of sirolimus liposome prepared by thin film hydration technique. - BioImpacts, in press, 2013.
34. Basan H., Göǧer N.G., Ertaş N., Orbey M.T. - Quantitative determination of piroxicam in a new formulation (piroxicam-β-cyclodextrin) by derivative UV spectrophotometric method and HPLC. - J. Pharm. Biomed. Anal., 26 (2), 171-8, 2001. (Pubitemid 32709932)
35. Cevc G., Blume G. - New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. - Biochim. Biophys. Acta (BBA), Biomembranes, 1514 (2), 191-205, 2001. (Pubitemid 32831008)
36. Cevc G., Blume G., Schätzlein A., Gebauer D., Paul A. - The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. - Adv. Drug Del. Rev., 18 (3), 349-78, 1996. (Pubitemid 26063309)
37. Elsayed M.M.A., Abdallah O.Y., Naggar V.F., Khalafallah N.M.- Lipid vesicles for skin delivery of drugs: Reviewing three decades of research. - Int. J. Pharm., 332 (1-2), 1-16, 2007.
38. Erdoǧan S., Özer A.Y., Bilgili H. - In vivo behaviour of vesicular urokinase. - Int. J. Pharm., 295 (1-2), 1-6, 2005.
39. Bavarsad N., Fazly Bazzaz B.S., Khamesipour A., Jaafari M.R.- Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice. - Acta Trap., 124 (1), 33-41, 2012.
40. Elhissi A.M.A., Giebultowicz J., Stec A.A., Wroczynski P., Ahmed W., Alhnan M.A., Phoenix D., Taylor K.M.G. - Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients. - Int. J. Pharm., 436 (1-2), 519-26, 2012.
41. Cevc G., Schätzlein A., Richardsen H. - Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. - Biochim. Biophys. Acta (BBA), Biomembranes, 1564 (1), 21-30, 2002. (Pubitemid 34717865)